Search hospitals > Massachusetts > Boston

Joslin Diabetes Center

Claim this profile
Boston, Massachusetts 02215
Global Leader in Diabetes
Global Leader in Type 1 Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Low Blood Sugar
Conducts research for Diabetic Retinopathy
169 reported clinical trials
17 medical researchers
Photo of Joslin Diabetes Center in BostonPhoto of Joslin Diabetes Center in BostonPhoto of Joslin Diabetes Center in Boston

Summary

Joslin Diabetes Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Low Blood Sugar, Diabetic Retinopathy and other specialties. Joslin Diabetes Center is involved with conducting 169 clinical trials across 81 conditions. There are 17 research doctors associated with this hospital, such as Osama Hamdy, Jason Gaglia, Dr., Mary E Patti, MD, and Lori Laffel.

Area of expertise

1Diabetes
Global Leader
Joslin Diabetes Center has run 88 trials for Diabetes. Some of their research focus areas include:
GAD65 positive
IA-2 positive
ZnT8 positive
2Type 1 Diabetes
Global Leader
Joslin Diabetes Center has run 63 trials for Type 1 Diabetes. Some of their research focus areas include:
HLA positive
GAD65 positive
IA-2 positive

Top PIs

Clinical Trials running at Joslin Diabetes Center

Type 1 Diabetes
Diabetes
Type 2 Diabetes
Obesity
Eating Disorders
Macular Pucker
Retinal Disease
Diabetic Retinopathy
Metabolic Syndrome
Low Blood Sugar
Image of trial facility.

Eating Disorder Prevention Program

for Type 1 Diabetes

This study aims to test the effectiveness of an evidence-based eating-disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.
Recruiting1 award N/A4 criteria
Image of trial facility.

Lifestyle Intervention

for Diabetes

This study is evaluating whether a lifestyle intervention can help improve epigenetic markers in overweight men with type 1 or type 2 diabetes.
Recruiting1 award N/A5 criteria
Image of trial facility.

DIAGNODE-3 study

for recently diagnosed type I diabetes

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with oral Vitamin D supplementation, to preserve endogenous beta cell function and influence glycemic parameters in adolescent and adults recently diagnosed with T1D carrying the HLA DR3-DQ2 haplotype.
Recruiting1 award Phase 32 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Joslin Diabetes Center?
Joslin Diabetes Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Low Blood Sugar, Diabetic Retinopathy and other specialties. Joslin Diabetes Center is involved with conducting 169 clinical trials across 81 conditions. There are 17 research doctors associated with this hospital, such as Osama Hamdy, Jason Gaglia, Dr., Mary E Patti, MD, and Lori Laffel.